216 related articles for article (PubMed ID: 2387813)
1. Preliminary experience with allogeneic bone marrow transplantation in haematological disorders in India.
Saikia TK; Advani SH; Gopal R; Nair CN; Dinsha KA; Kurkure PA; Swaroop VS; Jagannath P; Sharma S; Rao RS
J Assoc Physicians India; 1990 May; 38(5):332-4. PubMed ID: 2387813
[TBL] [Abstract][Full Text] [Related]
2. Importance of bone marrow cell dose in bone marrow transplantation.
Paulin T
Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation for leukaemia and aplastic anaemia. Results of the Leipzig BMT Group.
Helbig W; Kubel M; Schwenke H; Thierbach V; Hoffmann FA; Standke E; Feyer P; Haustein B; Pönisch W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):383-7. PubMed ID: 2480278
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation at The Mount Sinai Hospital.
Fruchtman SM; Scigliano E; Ross V; Abramowitz A; Lipton J; Mandell L; Shank B
Mt Sinai J Med; 1994 Jan; 61(1):3-12. PubMed ID: 8183289
[No Abstract] [Full Text] [Related]
6. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
8. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
[TBL] [Abstract][Full Text] [Related]
9. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
[TBL] [Abstract][Full Text] [Related]
10. Current status of bone marrow transplantation.
Bortin MM; Horowitz MM
Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
[TBL] [Abstract][Full Text] [Related]
11. Status of allogeneic bone marrow transplantation in childhood in the GDR.
Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Burger E; Goetz I; Kob D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):389-96. PubMed ID: 2480279
[TBL] [Abstract][Full Text] [Related]
12. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
Labar B; Bogdanic V; Kastelan A; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B; Francetic I; Dobric I; Grgicevic D; Kerhin-Brkljacic V
Biomed Pharmacother; 1986; 40(9):332-7. PubMed ID: 3548836
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for leukaemia in Europe.
Gratwohl A; Hermans J; Lyklema A; Zwaan FE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):353-60. PubMed ID: 2480274
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.
Marks DI; Dousset B; Robson A; Imvrios G; Buckels JA; Elias E; Neuberger JM; Foster C; Batchelor R; Goldman JM
Bone Marrow Transplant; 1992 Nov; 10(5):463-6. PubMed ID: 1464011
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease following allogeneic bone marrow transplantation.
Yoshikawa S; Akao Y; Hiraiwa A; Sao H; Yamauchi T; Tahara T; Yoshikawa H; Matsuyama K; Kimura S; Kitayama S
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():509-18. PubMed ID: 6394814
[TBL] [Abstract][Full Text] [Related]
18. Second bone marrow transplantation after leukemia relapse in 11 patients.
Wagner JE; Santos GW; Burns WH; Saral R
Bone Marrow Transplant; 1989 Jan; 4(1):115-8. PubMed ID: 2647176
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Galimberti M; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Giardini C; Gaziev D; Erer B; Ripalti M; Rapa S
Bone Marrow Transplant; 1994 Feb; 13(2):197-201. PubMed ID: 8205089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
